in

The ‘Prefilled Syringes Market (5th edition), 2019-2030’ report features an extensive study of the c

To order this detailed 800+ page report, please visit this link

Key Inclusions

An overview of the current market landscape of companies engaged in manufacturing prefilled syringes, providing information on year of establishment, company size, geographical location of the headquarters and manufacturing facilities, type of material used (glass and plastic), number of barrel chambers (single chamber and dual chamber), type of needle system (fixed needle system, luer lock and luer cone) and syringe volume.

An overview of the current market landscape of companies that are developing drugs in combination with prefilled syringes, featuring information on year of establishment, company size, geographical location of the developers, target therapeutic area, phases of development, type of drug molecule, route of administration, approval year (for marketed products), dosage details (for marketed products) and other approved dosage forms (for marketed products).

A detailed competitiveness analysis of the various prefilled syringes that we came across, taking into consideration the supplier power (based on the employee size of developer / manufacturer and their respective annual revenues) and key product specifications, such as number of chambers in the barrel, number of needle systems, volume of the barrel, technological advancement / user-friendliness and other distinguishing features.

A list of marketed drugs / therapies and pipeline candidates that are likely to be developed in combination with prefilled syringes in the near future, shortlisted based on an in-depth analysis that takes into consideration various relevant parameters, such as route of administration, type of drug molecule, target indications, other available dosage forms (for approved drugs) and historical annual sales information (for approved drugs).

An analysis presenting potential strategic partners (primarily drug developers) for prefilled syringe manufacturers (with regard to likely collaboration opportunities for combination product development) based on different parameters, such as pipeline strength, target therapeutic indication(s) and developer strength.

An analysis of the various prefilled syringe combination product-related initiatives of big pharma players, based on parameters, such as current adoption (based on number of approved and under development prefilled syringe combination products) and likely future adoption (based on potential injectable product candidates in the pipeline that are likely to be delivered via prefilled syringes), target therapeutic area(s) and type of drug molecule.

A review of the landscape of contract fill / finish services providers that offer services for prefilled syringes, featuring a list of active (large-sized) service providers and analysis based on a number of relevant parameters, such as year of establishment, company size, scale of operation (preclinical, clinical and commercial), type of drug molecule (biologics and small molecules), and geographical location of the service provider.

A detailed discussion on various safety features (add-on and integrated devices) installed in recent versions of prefilled syringes and the companies involved in developing and manufacturing such solutions.

An informative summary of various guidelines established and issued by major regulatory bodies for the approval of prefilled syringes, across different countries / geographical regions. 

Brief discussions of currently available specialty syringes, which include prefilled flush syringes, prefilled diluent syringe systems and prefilled contrast agent delivery systems.

A case study on companies that are engaged in the manufacturing of autoinjectors, featuring brief profiles of key players in this domain; each profile includes an overview of the firm, and information on its respective product portfolio.

Elaborate profiles of prominent prefilled syringe manufacturers engaged in this domain, featuring a brief overview of the company, its financial information (if available), information on product portfolio, recent developments and an informed future outlook.

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

  • Target therapeutic area

Autoimmune disorders

Infectious diseases

Neurological disorders

Blood disorders

Oncological disorders

Psychiatric disorders

Respiratory disorders

Cardiovascular disorders

Metabolic disorders

Ophthalmic diseases

Orthopedic disorders

Others

  • Type of syringe

Specialty syringes

  • Type of syringe barrel material

Glass

Plastic

  • Number of barrel chambers

Single chamber

Dual chamber

  • Key geographical regions

North America

Europe

Latin America

Asia Pacific

Middle East and Africa

To request sample pages, please visit this link

Key Questions Answered

  • Who are the key players engaged in the manufacturing of prefilled syringes, across the globe?
  • What are the prevalent trends within the prefilled syringes market?
  • What are the current regulatory requirements for securing marketing authorizations for prefilled syringe combination products, across different countries?
  • What technological advances have taken place in the prefilled syringes market?
  • What are the key growth drivers within the prefilled syringes market?
  • Who are the key contract service providers in this domain?
  • How is the current and future market opportunity likely to be distributed across key market segments?

You may also be interested in the following titles:

Contact Us

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

This post was created with our nice and easy submission form. Create your post!

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Loading…

0

What do you think?

Presently, around 80 types of prefilled syringes are available in the market, and several companies

Disrupting a USD 600 Billion Mining Industry with Blockchain: Interview with GCGC CEO and CTA